Pattern of Adverse Effets of COVID-19 Vaccine Among the People of Bangladesh: An International Journal of Medical Toxicology and Drug Experience

ABSTRACT

Introduction: Since the WHO classified COVID-19 a pandemic, vaccines have been developed to minimize the SARS-CoV-2 virus's incidence around the world. [1] For better understanding of the safety and effectiveness of the vaccines the identification of the localized and systemic side-effects after vaccination is important because the side effects between in a real-world community setting than reported in phase 3 trials, mostly minor in severity, and self-limiting. [2-5] Objective: To identify pattern of adverse effects of covid-19 vaccine among the people of Bangladesh. Methods: This follow up study was conducted among 2345 vaccinated people at Bangabandhu Sheikh Mujib Medical University from June 2021 to December 2021. Data was collected by face to face and telephone interviewing through a structured questionnaire for 7 days daily for local effect and upto 28 days for systemic side effects after vaccination and SPSS software version 25.0 was used for statistical analysis Results: Among the total participants 2345, Most of the people were male 1565 (66.7%). 17.1% of people had local side effects. About 33.1% participants were experienced systemic side effects. Among the local side effects pain was more common and chill and shiver in systemic effects respectively 14.3% and 2%. About 89.1% participants were with co morbidity. Male were predominant and middle aged were more than older people. Conclusion: This study portrayed a precise scenario about the adverse effects of vaccine. The adverse effects of vaccine should be evidence based. Further education and research needed to encourage on evidenced based vaccination among the people. This was generated information for the clinical care providers to take necessary steps as a precaution in treating the adverse effects of any patients and the policy makers to take necessary steps in related to vaccine to handle this pandemic.